BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2920500)

  • 1. Individual variability in the blood pressure response to intravenous phenylpropanolamine: a pharmacokinetic and pharmacodynamic investigation.
    O'Connell MB; Pentel PR; Zimmerman CL
    Clin Pharmacol Ther; 1989 Mar; 45(3):252-9. PubMed ID: 2920500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dispositional factors do not contribute to the enantiospecificity of the cardiovascular effects of phenylpropanolamine.
    Stockley CS; Wing LM; Tonkin AL; Miners JO
    Clin Pharmacol Ther; 1994 Jan; 55(1):35-43. PubMed ID: 8299314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacodynamic interaction between caffeine and phenylpropanolamine.
    Brown NJ; Ryder D; Branch RA
    Clin Pharmacol Ther; 1991 Oct; 50(4):363-71. PubMed ID: 1914371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of single-dose phenylpropanolamine on blood pressure in patients with hypertension controlled by beta blockers.
    O'Connell MB; Gross CR
    Pharmacotherapy; 1990; 10(2):85-91. PubMed ID: 2349137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of phenylpropanolamine on ambulatory blood pressure.
    Goodman RP; Wright JT; Barlascini CO; McKenney JM; Lambert CM
    Clin Pharmacol Ther; 1986 Aug; 40(2):144-7. PubMed ID: 3731678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of phenylpropanolamine and associated effects on blood pressure in normotensive subjects: a pilot-study.
    Dowse R; Scherzinger SS; Kanfer I
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):205-10. PubMed ID: 2194987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of urine pH modification on the pharmacokinetics and pharmacodynamics of phenylpropanolamine.
    Zimmerman CL; O'Connell MB; Soria I
    Pharm Res; 1990 Jan; 7(1):96-102. PubMed ID: 2300545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phenylpropanolamine hydrochloride on blood pressure in Korean patients with hypertension controlled by hydrochlorothiazide.
    Sands CD; Jung KM; Jones DW; Kim HJ
    Clin Pharm; 1992 Feb; 11(2):168-73. PubMed ID: 1551298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of phenylpropanolamine on blood pressure during upright bicycle exercise in normal subjects.
    Davies SF; McArthur CD; Husebye DG; Maddy MM; O'Connell MB; Pentel PR
    Int J Obes; 1989; 13(4):505-10. PubMed ID: 2676877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of multiple doses of phenylpropanolamine on the blood pressure of patients whose hypertension was controlled with beta blockers.
    O'Connell MB; Gross CR
    Pharmacotherapy; 1991; 11(5):376-81. PubMed ID: 1684039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent response to phenylpropanolamine: inhibition of orthostasis.
    Lake CR; Rosenberg DB; Gallant S; Zaloga G; Chernow B
    J Clin Pharmacol; 1991 Jul; 31(7):624-35. PubMed ID: 1894758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylpropanolamine increases plasma caffeine levels.
    Lake CR; Rosenberg DB; Gallant S; Zaloga G; Chernow B
    Clin Pharmacol Ther; 1990 Jun; 47(6):675-85. PubMed ID: 2357862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic doses of phenylpropanolamine increase supine systolic blood pressure.
    Pentel PR; Aaron C; Paya C
    Int J Obes; 1985; 9(2):115-9. PubMed ID: 4030197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in blood pressure following escalating doses of phenylpropanolamine and a suggested protocol for monitoring.
    Segev G; Westropp JL; Kulik C; Lavy E
    Can Vet J; 2015 Jan; 56(1):39-43. PubMed ID: 25565712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acute effect of phenylpropanolamine and brompheniramine on blood pressure in controlled hypertension: a randomized double-blind crossover trial.
    Petrulis AS; Imperiale TF; Speroff T
    J Gen Intern Med; 1991; 6(6):503-6. PubMed ID: 1684991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular differences between phenylpropanolamine and its related norephedrine isomers in the rat.
    Moya-Huff FA; Kiritsy PJ; Maher TJ
    J Pharm Sci; 1987 Feb; 76(2):114-6. PubMed ID: 3572747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double dose of phenylpropanolamine causes transient hypertension.
    Lake CR; Zaloga G; Clymer R; Quirk RM; Chernow B
    Am J Med; 1988 Sep; 85(3):339-43. PubMed ID: 3414729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of phenylpropanolamine on 24-hour blood pressure in normotensive subjects administered indomethacin.
    McKenney JM; Wright JT; Katz GM; Goodman RP
    DICP; 1991 Mar; 25(3):234-9. PubMed ID: 2028627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the pressor effect of phenylpropanolamine in healthy subjects.
    Blackburn GL; Morgan JP; Lavin PT; Noble R; Funderburk FR; Istfan N
    JAMA; 1989 Jun; 261(22):3267-72. PubMed ID: 2716162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations.
    Horowitz JD; Lang WJ; Howes LG; Fennessy MR; Christophidis N; Rand MJ; Louis WJ
    Lancet; 1980 Jan; 1(8159):60-1. PubMed ID: 6153233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.